Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Short-Term Debt issuances (2019 - 2025)

Sanara MedTech (SMTI) has disclosed Short-Term Debt issuances for 6 consecutive years, with -$44433.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Short-Term Debt issuances changed N/A year-over-year to -$44433.0, compared with a TTM value of $12.0 million through Sep 2025, down 21.05%, and an annual FY2024 reading of $29.3 million, up 202.83% over the prior year.
  • Short-Term Debt issuances was -$44433.0 for Q2 2025 at Sanara MedTech, down from $12.1 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $15.2 million in Q3 2024 and bottomed at -$44433.0 in Q2 2025.
  • Average Short-Term Debt issuances over 3 years is $7.0 million, with a median of $6.4 million recorded in 2021.